Welcome to LookChem.com Sign In|Join Free

CAS

  • or

152-58-9

Post Buying Request

152-58-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

152-58-9 Usage

Chemical Properties

Crystalline Solid

Uses

Different sources of media describe the Uses of 152-58-9 differently. You can refer to the following data:
1. Glucocorticoid receptor binding
2. 11-Deoxy Cortisol (Hydrocortisone EP Impurity F) is a glucocorticoid receptor binding.

Check Digit Verification of cas no

The CAS Registry Mumber 152-58-9 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,5 and 2 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 152-58:
(5*1)+(4*5)+(3*2)+(2*5)+(1*8)=49
49 % 10 = 9
So 152-58-9 is a valid CAS Registry Number.

152-58-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (C1478)  Cortexolone  >98.0%(HPLC)

  • 152-58-9

  • 1g

  • 660.00CNY

  • Detail

152-58-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name 11-deoxycortisol

1.2 Other means of identification

Product number -
Other names CORTEXOLONE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:152-58-9 SDS

152-58-9Synthetic route

(8R,9S,10R,13S,14S)-10,13-Dimethyl-17-[1-tripropylsilanyloxy-eth-(Z)-ylidene]-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
110801-53-1

(8R,9S,10R,13S,14S)-10,13-Dimethyl-17-[1-tripropylsilanyloxy-eth-(Z)-ylidene]-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
With potassium hydrogencarbonate; 3-chloro-benzenecarboperoxoic acid88%
cortexolone 21-acetate
640-87-9

cortexolone 21-acetate

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
With water; potassium carbonate In methanol at 20℃; for 3h; Inert atmosphere;85%
With methanol; potassium hydrogencarbonate
17,21-diacetoxy-4-pregnene-3,20-dione
1807-15-4

17,21-diacetoxy-4-pregnene-3,20-dione

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
With potassium hydroxide In methanol Ambient temperature;80%
With potassium hydroxide
C25H37BrNO2(1+)*Cl(1-)

C25H37BrNO2(1+)*Cl(1-)

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
With water; potassium carbonate In acetone at 20℃; for 72h; Inert atmosphere;70%
21-bromo-17α-hydroxy-4-pregnene-3,20-dione
20380-17-0

21-bromo-17α-hydroxy-4-pregnene-3,20-dione

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
With potassium carbonate for 0.166667h; Heating;68%
With water; potassium carbonate In acetone at 20℃; for 0.5h; Inert atmosphere;57%
cortexolone 21-acetate
640-87-9

cortexolone 21-acetate

A

Cortexolone
152-58-9

Cortexolone

B

9α-hydroxycortexolone
566-12-1

9α-hydroxycortexolone

Conditions
ConditionsYield
With disodium hydrogenphosphate; potassium dihydrogenphosphate; D-glucose; menadione; corn-steep liquor In water; N,N-dimethyl-formamide at 28℃; for 40h; Rhodococcus sp.;A 30%
B 50%
pyridine
110-86-1

pyridine

17.20βF-dihydroxy-3-oxo-pregnen-(4)-al-(21)
59005-57-1

17.20βF-dihydroxy-3-oxo-pregnen-(4)-al-(21)

Cortexolone
152-58-9

Cortexolone

21-Hydroxyprogesterone
64-85-7

21-Hydroxyprogesterone

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
mit Hilfe von Trichothecium roseum;
21-Hydroxyprogesterone
64-85-7

21-Hydroxyprogesterone

A

Cortexolone
152-58-9

Cortexolone

B

6β,21-dihydroxypregna-4-en-3,20-dione
298-65-7

6β,21-dihydroxypregna-4-en-3,20-dione

Conditions
ConditionsYield
mit Hilfe von Trichothecium roseum;
17.20βF-dihydroxy-3-oxo-pregnen-(4)-al-(21)
59005-57-1

17.20βF-dihydroxy-3-oxo-pregnen-(4)-al-(21)

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
With pyridine
Progesterone
57-83-0

Progesterone

A

HYDROCORTISONE
50-23-7

HYDROCORTISONE

B

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

C

21-Hydroxyprogesterone
64-85-7

21-Hydroxyprogesterone

D

Corticosterone
50-22-6

Corticosterone

E

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
With glucose-6-phosphate dehydrogenase; phosphate buffer; air; α-D-glucose 6-phosphate; midterm female fetal human adrenal tissue; NADP; magnesium chloride at 37℃; for 2h; Product distribution; <3H>labeled;A 36.3 % Chromat.
B n/a
C n/a
D 4.7 % Chromat.
E n/a
Progesterone
57-83-0

Progesterone

A

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

B

21-Hydroxyprogesterone
64-85-7

21-Hydroxyprogesterone

C

Corticosterone
50-22-6

Corticosterone

D

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
With glucose-6-phosphate dehydrogenase; phosphate buffer; air; α-D-glucose 6-phosphate; midterm female fetal human kidney tissue; NADP; magnesium chloride at 37℃; for 2h; Product distribution; <3H>labeled;A 2.3 % Chromat.
B 21.1 % Chromat.
C n/a
D 32.5 % Chromat.
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

A

HYDROCORTISONE
50-23-7

HYDROCORTISONE

B

testosterone
58-22-0

testosterone

C

Androstenedione
63-05-8

Androstenedione

D

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
With D-glucose 6-phosphate; sporadic adrenal pheochromocytomas; oxygen; NADP; glucose 6-phosphate dehydrogenase at 37℃; for 1h; Product distribution; <4-14C>-labeled;A 20.6 % Turnov.
B 1.1 % Turnov.
C 2.3 % Turnov.
D 14.8 % Turnov.
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
With α-D-glucose 6-phosphate; 21-hydroxylase from human fetal adrenals; glucose-6-phosphate-dehydrogenase; potassium chloride; 2-amino-2-hydroxymethyl-1,3-propanediol; magnesium chloride Equilibrium constant; interaction with cytochrome P-450 obtained from microsomes and mitochondria from human fetal adrenals in dependence on conc.; apparent spectral dissociation const.; inhibition by danazol;
With CYP21 Enzymatic reaction;
With recombinant human cytochrome P450 21A2; water In aq. phosphate buffer at 37℃; Enzymatic reaction;
With wild-type human cytochrome P450 21A2 Kinetics; Reagent/catalyst; Enzymatic reaction;
methanol
67-56-1

methanol

16α,17α-epoxyprogesterone
1097-51-4, 16356-47-1

16α,17α-epoxyprogesterone

A

Cortexolone
152-58-9

Cortexolone

B

20,20-dimethoxy-16α,17α-epoxypregn-4-en-21-ol-3-one
119005-10-6

20,20-dimethoxy-16α,17α-epoxypregn-4-en-21-ol-3-one

Conditions
ConditionsYield
With potassium hydroxide; [bis(acetoxy)iodo]benzene at 20℃; for 7h;A 0.08 g
B 0.15 g
16α,17α-epoxyprogesterone
1097-51-4, 16356-47-1

16α,17α-epoxyprogesterone

A

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

B

Cortexolone
152-58-9

Cortexolone

C

16α,17α-epoxypregn-4-en-21-ol-3,20-dione
100167-82-6

16α,17α-epoxypregn-4-en-21-ol-3,20-dione

Conditions
ConditionsYield
With potassium hydroxide; [bis(acetoxy)iodo]benzene In methanol at 20℃; for 8h;A 0.02 g
B 0.02 g
C 0.19 g
Pregnenolone
145-13-1

Pregnenolone

A

HYDROCORTISONE
50-23-7

HYDROCORTISONE

B

testosterone
58-22-0

testosterone

C

Androstenedione
63-05-8

Androstenedione

D

21-Hydroxyprogesterone
64-85-7

21-Hydroxyprogesterone

E

Corticosterone
50-22-6

Corticosterone

F

Cortexolone
152-58-9

Cortexolone

G

DHEA

DHEA

Conditions
ConditionsYield
With D-glucose 6-phosphate; sporadic adrenal pheochromocytomas; oxygen; NADP; glucose 6-phosphate dehydrogenase at 37℃; for 1h; Product distribution; <4-14C>-labeled;A 12.6 % Turnov.
B 0.9 % Turnov.
C 1.9 % Turnov.
D 2.4 % Turnov.
E 6.8 % Turnov.
F 2.3 % Turnov.
G n/a
C26H37NO5

C26H37NO5

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 80 percent
2: hydrolysis
3: 80 percent / KOH / methanol / Ambient temperature
View Scheme
C28H39NO7
84542-27-8

C28H39NO7

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrolysis
2: 80 percent / KOH / methanol / Ambient temperature
View Scheme
17-Hydroxypregnenolone
387-79-1

17-Hydroxypregnenolone

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 10 percent / CuBr2 / tetrahydrofuran / 2 h / Heating
2: 65 percent / 8 N CrO3 / acetone / 0.08 h
3: 68 percent / aq. K2CO3 / 0.17 h / Heating
View Scheme
21-bromo-3β,17α-dihydroxy-5-pregnen-20-one
2827-40-9

21-bromo-3β,17α-dihydroxy-5-pregnen-20-one

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 65 percent / 8 N CrO3 / acetone / 0.08 h
2: 68 percent / aq. K2CO3 / 0.17 h / Heating
View Scheme
16-dehydroprogesterone
1096-38-4

16-dehydroprogesterone

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 79 percent / RhCl(PPh3)3
2: 88 percent / mCPBA, KHCO3
View Scheme
17-hydroxy-20βF-acetoxy-3-oxo-pregnen-(4)-al-(21)

17-hydroxy-20βF-acetoxy-3-oxo-pregnen-(4)-al-(21)

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aqueous methanol.KHCO3
2: pyridine
View Scheme
Progesterone
57-83-0

Progesterone

A

21-Hydroxyprogesterone
64-85-7

21-Hydroxyprogesterone

B

2β,16β-hydroxyprogesterone
1334177-12-6

2β,16β-hydroxyprogesterone

C

Cortexolone
152-58-9

Cortexolone

E

2beta-Hydroxyprogesterone
604-29-5, 604-28-4, 123287-83-2

2beta-Hydroxyprogesterone

Conditions
ConditionsYield
With Bacillus megaterium cytochrome P450 BM3 monooxygenase (V78L/A82F/F87A)-expressing cells at 25℃; for 24h; diastereoselective reaction;
Progesterone
57-83-0

Progesterone

A

21-Hydroxyprogesterone
64-85-7

21-Hydroxyprogesterone

B

Cortexolone
152-58-9

Cortexolone

D

2beta-Hydroxyprogesterone
604-29-5, 604-28-4, 123287-83-2

2beta-Hydroxyprogesterone

Conditions
ConditionsYield
With Bacillus megaterium cytochrome P450 BM3 monooxygenase (R47Y/T49F/V78T/A82F/F78A)-expressing cells at 25℃; for 24h; diastereoselective reaction;
Progesterone
57-83-0

Progesterone

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: CYP17A1 / Enzymatic reaction
2: CYP21 / Enzymatic reaction
View Scheme
3-O-ethoxypregnenolone

3-O-ethoxypregnenolone

A

Androstenedione
63-05-8

Androstenedione

B

Cortexolone
152-58-9

Cortexolone

C

R-16α,17-dihydroxy-pregn-4-ene-3,20-dione
595-77-7

R-16α,17-dihydroxy-pregn-4-ene-3,20-dione

D

C21H30O5

C21H30O5

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: potassium tert-butylate; oxygen / tetrahydrofuran; tert-butyl alcohol / 4.67 h / 20 °C
2: acetic acid / methanol / 3 h / 20 °C
3: 1,2-dilauroyl-sn-glicero-3-phosphatidylcholine; zebrafish P450 17A2 enzyme / aq. phosphate buffer; ethanol; dimethyl sulfoxide / 37 °C / pH 7.4 / Enzymatic reaction
4: zebrafish P450 17A1 enzyme; 1,2-dilauroyl-sn-glicero-3-phosphatidylcholine / aq. phosphate buffer / 37 °C / pH 7.4 / Enzymatic reaction
View Scheme
3-O-ethoxypregnenolone

3-O-ethoxypregnenolone

A

Cortexolone
152-58-9

Cortexolone

B

R-16α,17-dihydroxy-pregn-4-ene-3,20-dione
595-77-7

R-16α,17-dihydroxy-pregn-4-ene-3,20-dione

C

C21H30O5

C21H30O5

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: potassium tert-butylate; oxygen / tetrahydrofuran; tert-butyl alcohol / 4.67 h / 20 °C
2: acetic acid / methanol / 3 h / 20 °C
3: 1,2-dilauroyl-sn-glicero-3-phosphatidylcholine; zebrafish P450 17A2 enzyme / aq. phosphate buffer; ethanol; dimethyl sulfoxide / 37 °C / pH 7.4 / Enzymatic reaction
4: 1,2-dilauroyl-sn-glicero-3-phosphatidylcholine; zebrafish b5 enzyme; NADPH-P450 reductase; zebrafish P450 17A2 enzyme / aq. phosphate buffer / 37 °C / pH 7.4 / Enzymatic reaction
View Scheme
C23H36O4

C23H36O4

A

Androstenedione
63-05-8

Androstenedione

B

Cortexolone
152-58-9

Cortexolone

C

R-16α,17-dihydroxy-pregn-4-ene-3,20-dione
595-77-7

R-16α,17-dihydroxy-pregn-4-ene-3,20-dione

D

C21H30O5

C21H30O5

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: acetic acid / methanol / 3 h / 20 °C
2: 1,2-dilauroyl-sn-glicero-3-phosphatidylcholine; zebrafish P450 17A2 enzyme / aq. phosphate buffer; ethanol; dimethyl sulfoxide / 37 °C / pH 7.4 / Enzymatic reaction
3: zebrafish P450 17A1 enzyme; 1,2-dilauroyl-sn-glicero-3-phosphatidylcholine / aq. phosphate buffer / 37 °C / pH 7.4 / Enzymatic reaction
View Scheme
Cortexolone
152-58-9

Cortexolone

acetic anhydride
108-24-7

acetic anhydride

cortexolone 21-acetate
640-87-9

cortexolone 21-acetate

Conditions
ConditionsYield
With pyridine at 20℃; for 0.5h;100%
With pyridine
Cortexolone
152-58-9

Cortexolone

21-dehydrohydrocortexolone dimer

21-dehydrohydrocortexolone dimer

Conditions
ConditionsYield
With air; copper diacetate In methanol for 5h;100%
Cortexolone
152-58-9

Cortexolone

pivaloyl chloride
3282-30-2

pivaloyl chloride

17-Hydroxy-21-trimethylacetoxy-4-pregnen-3,20-dion
6920-52-1

17-Hydroxy-21-trimethylacetoxy-4-pregnen-3,20-dion

Conditions
ConditionsYield
With dmap In pyridine at 0℃; for 2h;99%
With pyridine; dichloromethane
Cortexolone
152-58-9

Cortexolone

methanesulfonyl chloride
124-63-0

methanesulfonyl chloride

17α-hydroxy-21-<(methylsulfonyl)oxy>pregn-4-ene-3,20-dione
82427-84-7

17α-hydroxy-21-<(methylsulfonyl)oxy>pregn-4-ene-3,20-dione

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 1h;97%
triethylsilane
617-86-7

triethylsilane

Cortexolone
152-58-9

Cortexolone

17-hydroxy-21-(triethylsiloxy)pregn-4-ene-3,20-dione

17-hydroxy-21-(triethylsiloxy)pregn-4-ene-3,20-dione

Conditions
ConditionsYield
AuCl(xanthphos) In chloroform; N,N-dimethyl-formamide at 50℃; for 6h;96%
Cortexolone
152-58-9

Cortexolone

17,21,21-trihydroxy-4-pregnene-3,20-dione
84869-31-8

17,21,21-trihydroxy-4-pregnene-3,20-dione

Conditions
ConditionsYield
With copper diacetate; air In methanol for 7h; Ambient temperature;95%
Cortexolone
152-58-9

Cortexolone

11β,20-dihydroxy-3-oxo-4,cis-17(20)-pregnadien-21-al
105562-13-8

11β,20-dihydroxy-3-oxo-4,cis-17(20)-pregnadien-21-al

Conditions
ConditionsYield
With oxone; 2-Iodobenzoic acid In dimethyl sulfoxide at 75℃; for 12h; Inert atmosphere;92%
Cortexolone
152-58-9

Cortexolone

20-hydroxy-3,11-dioxo-4,cis-17(20)-pregnadien-21-al
118916-30-6

20-hydroxy-3,11-dioxo-4,cis-17(20)-pregnadien-21-al

Conditions
ConditionsYield
With oxone; 2-Iodobenzoic acid In dimethyl sulfoxide at 75℃; for 12h; Inert atmosphere;92%
Isopropenyl acetate
108-22-5

Isopropenyl acetate

Cortexolone
152-58-9

Cortexolone

cortexolone 21-acetate
640-87-9

cortexolone 21-acetate

Conditions
ConditionsYield
With Rhizopus oryzae lipase immobilized on Lewatit 1600 resin In di-isopropyl ether at 55℃; for 48h; regioselective reaction;91%
Cortexolone
152-58-9

Cortexolone

20-hydroxy-3-oxo-4,cis-17(20)-pregnadien-21-al
118864-85-0

20-hydroxy-3-oxo-4,cis-17(20)-pregnadien-21-al

Conditions
ConditionsYield
With oxone; 2-Iodobenzoic acid In dimethyl sulfoxide at 75℃; for 12h; Inert atmosphere;89%
Cortexolone
152-58-9

Cortexolone

2-Mercaptobenzothiazole
149-30-4

2-Mercaptobenzothiazole

(8R,10R,13S,14S,17R)-17-(2-(benzo[d]thiazol-2-ylthio)acetyl)-17-hydroxy-10,13-dimethyl1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one

(8R,10R,13S,14S,17R)-17-(2-(benzo[d]thiazol-2-ylthio)acetyl)-17-hydroxy-10,13-dimethyl1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one

Conditions
ConditionsYield
With fluorosulfonyl fluoride; 1,8-diazabicyclo[5.4.0]undec-7-ene In N,N-dimethyl-formamide at 20℃; for 0.166667h;88%
hexanes-ethyl acetate

hexanes-ethyl acetate

Cortexolone
152-58-9

Cortexolone

methyl 17α-hydroxy-3-oxoandrost-4-ene-17-carboxylate
10486-86-9

methyl 17α-hydroxy-3-oxoandrost-4-ene-17-carboxylate

Conditions
ConditionsYield
With sulfuric acid; sodium hydrogencarbonate In methanol87%
Cortexolone
152-58-9

Cortexolone

Androstenedione
63-05-8

Androstenedione

Conditions
ConditionsYield
In water; acetonitrile at 20℃; Electrochemical reaction;86%
With ammonium hydroxide; iodine In water; acetonitrile at 50℃; for 24h;78%
With manganese(IV) oxide In chloroform for 4h; Heating;67.6%
Cortexolone
152-58-9

Cortexolone

Bestmann ylide
73818-55-0, 15596-07-3

Bestmann ylide

4-((8R,9S,10R,13S,14S,17R)-17-Hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-5H-furan-2-one
18104-63-7

4-((8R,9S,10R,13S,14S,17R)-17-Hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-5H-furan-2-one

Conditions
ConditionsYield
In benzene for 3h; Heating;86%
Cortexolone
152-58-9

Cortexolone

methanesulfonyl chloride
124-63-0

methanesulfonyl chloride

17α-hydroxy-21-chloro-4-pregnene-3,20-dione
20380-16-9

17α-hydroxy-21-chloro-4-pregnene-3,20-dione

Conditions
ConditionsYield
With dmap In dichloromethane for 4h; Reflux;85%
Cortexolone
152-58-9

Cortexolone

17α-hydroxyandrost-4-en-3-one-17β-carboxylic acid
633-29-4

17α-hydroxyandrost-4-en-3-one-17β-carboxylic acid

Conditions
ConditionsYield
With sodium periodate In tetrahydrofuran; methanol at 20℃; for 2h;82%
With methanol; periodic acid
With periodic acid In methanol
Multi-step reaction with 2 steps
1: TsOH / dioxane; butan-2-one
2: aq. HIO4 / methanol
View Scheme
With sodium hydroxide; sulfuric acid In methanol; water; acetone
phthalimide
136918-14-4

phthalimide

Cortexolone
152-58-9

Cortexolone

2-(2-((8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl)isoindoline-1,3-dione

2-(2-((8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl)isoindoline-1,3-dione

Conditions
ConditionsYield
With fluorosulfonyl fluoride; 1,8-diazabicyclo[5.4.0]undec-7-ene In N,N-dimethyl-formamide at 20℃; for 0.166667h;82%
Cortexolone
152-58-9

Cortexolone

A

Progesterone
57-83-0

Progesterone

B

21-Hydroxyprogesterone
64-85-7

21-Hydroxyprogesterone

Conditions
ConditionsYield
With trimethylsilyl iodide In acetonitrile for 3h; Ambient temperature;A 5%
B 72%
With trimethylsilyl iodide In acetonitrile for 3h; Ambient temperature;A 5%
B 72%
With trimethylsilyl iodide In chloroform for 3h; Ambient temperature;A 53%
B 10%
With trimethylsilyl iodide In chloroform for 3h; Ambient temperature;A 38%
B 48%
formaldehyd
50-00-0

formaldehyd

Cortexolone
152-58-9

Cortexolone

17,20:20,21-bismethylenedioxy-4-pregnen-3-one
6173-64-4

17,20:20,21-bismethylenedioxy-4-pregnen-3-one

Conditions
ConditionsYield
With hydrogenchloride In chloroform; water at 20℃; for 5h;71%
With hydrogenchloride; chloroform
Cortexolone
152-58-9

Cortexolone

A

20-hydroxy-3-oxo-4,trans-17(20)-pregnadien-21-al
118864-86-1

20-hydroxy-3-oxo-4,trans-17(20)-pregnadien-21-al

B

20-hydroxy-3-oxo-4,cis-17(20)-pregnadien-21-al
118864-85-0

20-hydroxy-3-oxo-4,cis-17(20)-pregnadien-21-al

Conditions
ConditionsYield
With toluene-4-sulfonic acid In 1,4-dioxane Heating;A 10%
B 71%
With zinc diacetate; acetic acid Heating;A 6%
B 16.6%
With zinc diacetate; acetic acid Heating;A 6%
B 16.6%
Cortexolone
152-58-9

Cortexolone

17α,21-Dihydroxypregn-4-en-3,20-dione 21-phosphate
57099-41-9

17α,21-Dihydroxypregn-4-en-3,20-dione 21-phosphate

Conditions
ConditionsYield
With pyridine; 2-cyanoethyl phosphate; dicyclohexyl-carbodiimide70%
Cortexolone
152-58-9

Cortexolone

2,2-dimethoxy-propane
77-76-9

2,2-dimethoxy-propane

17,21-dihydroxy-3-methoxypregna-3,5-dien-20-one 17,21-acetonide
55388-55-1

17,21-dihydroxy-3-methoxypregna-3,5-dien-20-one 17,21-acetonide

Conditions
ConditionsYield
With toluene-4-sulfonic acid In N,N-dimethyl-formamide for 6h; Heating;61%
Cortexolone
152-58-9

Cortexolone

1-bromo-2,3,4-tri-O-acetyl-α-D-glucuronic acid methyl ester
21085-72-3

1-bromo-2,3,4-tri-O-acetyl-α-D-glucuronic acid methyl ester

pregn-4-en-17α,21-diol-3,20-dione-21-O-(methyl 2',3',4'-tri-O-acetyl-β-D-glucuronate)
105403-76-7

pregn-4-en-17α,21-diol-3,20-dione-21-O-(methyl 2',3',4'-tri-O-acetyl-β-D-glucuronate)

Conditions
ConditionsYield
With silver carbonate In toluene for 6h; Koenigs-Knorr synthesis; Reflux;48%
Cortexolone
152-58-9

Cortexolone

A

(8R,9S,10R,13S,14S,17R)-17-((R)-1,2-Dihydroxy-ethyl)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
128-19-8

(8R,9S,10R,13S,14S,17R)-17-((R)-1,2-Dihydroxy-ethyl)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one

B

4-pregnen-17α,20β,21-triol-3-one
3946-10-9

4-pregnen-17α,20β,21-triol-3-one

Conditions
ConditionsYield
With sodium tetrahydroborate; calcium chloride In water; ethyl acetate at -27℃;A n/a
B 40%

152-58-9Related news

Full spectroscopic characterization of two crystal pseudopolymorphic forms of the antiandrogen CORTEXOLONE (cas 152-58-9) 17α-propionate for topic application09/29/2019

Cortexolone-17α-propionate (CP) is a topically active antiandrogen useful in the treatment of skin disorders. In the solid state, three anhydrous forms of this drug (CPI, CPII and CPIII) occur, together with one hydrated crystal (CPW). The single crystal structure of the monohydrated phase, CPW...detailed

CORTEXOLONE (cas 152-58-9) 17α‐propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris. A pilot randomized, double‐blind comparative study vs. placebo and tretinoin 0·05% cream09/28/2019

Background  Acne vulgaris is a disorder of the pilosebaceous unit in which the androgens contribute to its onset and persistence. The use of antiandrogens is therefore potentially effective; however, antiandrogens for topical use are not available on the market. Cortexolone 17α‐propionate (CB‐...detailed

152-58-9Relevant articles and documents

Danazol Inhibits Human Adrenal 21- and 11β-Hydroxylation in vitro

Barbieri, Robert L.,Osathanondh, Rapin,Canick, Jacob A.,Stillman, Robert J.,Ryan, Kenneth J.

, p. 251 - 263 (1980)

The effects of danazol on steroidogenesis in vitro in the 16-20 week old human fetal adrenal were examined by studying: 1) danazol binding to adrenal microsomal and mitochondrial cytochrome P-450, and 2) enzyme kinetics of danazol inhibition of the adrenal microsomal 21-hydroxylase and the mitochondrial 11β-hydroxylase.The addition of danazol to preparations of adrenal microsomes or mitochondria elicited a type I cytochrome P-450 binding spectrum.Danazol bound to microsomal cytochrome P-450 with a high affinity apparent spectral dissociation constant (KS) of 1 μM and with a lower affinity K'S of 10 μM.Danazol bound to mitochondrial cytochrome P-450 with a KS of 5 μM.In addition, danazol competitively inhibited the microsomal 21-hydroxylase (apparent enzymatic inhibition constant KI = 0.8 μM) and the mitrochondrial 11β-hydroxylase (KI = 3 μM).These findings demonstrate that low concentrations of danazol directly inhibit steroidogenesis in the human fetal adrenal in vitro.

-

v.Euw,Reichstein

, p. 1140,1142 (1941)

-

Inherent steroid 17α,20-lyase activity in defunct cytochrome P450 17A enzymes

Gonzalez, Eric,Johnson, Kevin M.,Pallan, Pradeep S.,Phan, Thanh T.N.,Zhang, Wei,Lei, Li,Wawrzak, Zdzislaw,Yoshimoto, Francis K.,Egli, Martin,Peter Guengerich

, p. 541 - 556 (2018)

Cytochrome P450 (P450) 17A1 catalyzes the oxidations of progesterone and pregnenolone and is the major source of androgens. The enzyme catalyzes both 17α-hydroxylation and a subsequent 17α,20-lyase reaction, and several mechanisms have been proposed for the latter step. Zebrafish P450 17A2 catalyzes only the 17α-hydroxylations. We previously reported high similarity of the crystal structures of zebrafish P450 17A1 and 17A2 and human P450 17A1. Five residues near the heme, which differed, were changed. We also crystallized this five-residue zebrafish P450 17A1 mutant, and the active site still resembled the structure in the other proteins, with some important differences. These P450 17A1 and 17A2 mutants had catalytic profiles more similar to each other than did the wildtype proteins. Docking with these structures can explain several minor products, which require multiple enzyme conformations. The 17α-hydroperoxy (OOH) derivatives of the steroids were used as oxygen surrogates. Human P450 17A1 and zebrafish P450s 17A1 and P450 17A2 readily converted these to the lyase products in the absence of other proteins or cofactors (with catalytically competent kinetics) plus hydroxylated 17α-hydroxysteroids. The 17α-OOH results indicate that a "Compound I" (FeO3+) intermediate is capable of formation and can be used to rationalize the products. We conclude that zebrafish P450 17A2 is capable of lyase activity with the 17α-OOH steroids because it can achieve an appropriate conformation for lyase catalysis in this system that is precluded in the conventional reaction.

-

Reichstein,v.Euw

, p. 1258 (1940)

-

Conversion of progesterone to corticosteroids by the midterm fetal adrenal and kidney

McShane,deM. Fencl

, p. 299 - 310 (1983)

-

Human cytochrome P450 21A2, the major steroid 21-hydroxylase: Structure of the enzyme?progesterone substrate complex and rate-limiting C-H bond cleavage

Pallan, Pradeep S.,Wang, Chunxue,Lei, Li,Yoshimoto, Francis K.,Auchus, Richard J.,Waterman, Michael R.,Guengerich, F. Peter,Egli, Martin

, p. 13128 - 13143 (2015)

Cytochrome P450 (P450) 21A2 is the major steroid 21-hydroxylase, and deficiency of this enzyme is involved in ~95% of cases of human congenital adrenal hyperplasia, a disorder of adrenal steroidogenesis. A structure of the bovine enzyme that we published previously (Zhao, B., Lei, L., Kagawa, N., Sundaramoorthy, M., Banerjee, S., Nagy, L. D., Guengerich, F. P., and Waterman, M. R. (2012) Three-dimensional structure of steroid 21-hydroxylase (cytochrome P450 21A2) with two substrates reveals locations of disease-associated variants. J. Biol. Chem. 287, 10613-10622), containing two molecules of the substrate 17α-hydroxyprogesterone, has been used as a template for understanding genetic deficiencies. We have now obtained a crystal structure of human P450 21A2 in complex with progesterone, a substrate in adrenal 21-hydroxylation. Substrate binding and release were fast for human P450 21A2 with both substrates, and pre-steady-state kinetics showed a partial burst but only with progesterone as substrate and not 17α-hydroxyprogesterone. High intermolecular non-competitive kinetic deuterium isotope effects on both kcat and kcat/Km, from 5 to 11, were observed with both substrates, indicative of rate-limiting C-H bond cleavage and suggesting that the juxtaposition of the C21 carbon in the active site is critical for efficient oxidation. The estimated rate of binding of the substrate progesterone (kon 2.4 × 107 M-1 s-1) is only ~2-fold greater than the catalytic efficiency (kcat/Km = 1.3 × 107 M-1 s-1) with this substrate, suggesting that the rate of substrate binding may also be partially rate-limiting. The structure of the human P450 21A2-substrate complex provides direct insight into mechanistic effects of genetic variants.

P450BM3 on steroids: The Swiss Army Knife P450 enzyme just gets better

Wong, Luet-Lok

scheme or table, p. 2537 - 2539 (2012/05/07)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 152-58-9